Skip to main content
Keisa M. Lynch
( out of 90 reviews )

Keisa M. Lynch, DNP, APRN, FNP-C

Clinical Locations

Redwood Health Center

Gastroenterology
801-213-9900

University of Utah Hospital

Gastroenterology, Area E
801-213-9797
  • Keisa M. Lynch, DNP, APRN, FNP is a family nurse practitioner in the Department of Gastroenterology and Hepatology at the University of Utah School of Medicine and an Associate Professor at the University of Utah in the College of Nursing Doctorate Program. She is also the lead advanced practice provider (APP) within her division and a provider informaticist with EPIC. She also has special interests in inflammatory bowel disease and hepatology, especially viral hepatitis.

    Dr. Lynch completed her undergraduate degree in nursing at Weber State University followed by a Master’s of Science in Nursing (MSN) as a family nurse practitioner (FNP) at Westminster College. Dr. Lynch then completed her Doctor of Nursing Practice (DNP) degree at the University of Utah. Dr. Lynch has been recognized with the APP Clinical Excellence Award from the University of Utah internal medicine division and has lectured around the country on the topics of viral hepatitis, inflammatory bowel disease, non-alcoholic fatty liver disease, and how APPs can advance the academic and clinical mission. She was recently awarded a grant for assessing prevalence of hepatitis delta in Utah titled: The Changing Landscape: HDV Reflex Testing and Linkage to Care in the Utah Population. She is passionate about education, quality improvement, mentoring, professional development, leadership and research. Dr. Lynch is also a member of the American College of Gastroenterology Advanced Practice Providers committee and a co-mentor in Project HCV ECHO.

    Board Certification

    American Academy of Nurse Practitioners - ANP

    Patient Rating

    5.0 /5
    ( out of 90 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 25, 2023
    REDWOOD HEALTH CENTER

    Keisa is very kind and compassionate. She actually listens! She is very knowledgeable and explains everything thoroughly

    August 19, 2023
    REDWOOD HEALTH CENTER

    She is enjoyable to work with and is very knowledgeable

    August 19, 2023
    REDWOOD HEALTH CENTER

    Very informative and attentive to my medical needs.

    August 17, 2023
    SUGAR HOUSE HEALTH CENTER

    It is a long haul to get in touch with providers. Appointments are 2 months out and it is extremely difficult for immediate care. I think this is a departmental issue not Keisa. After pushing hard enough because of a possible new area of Crohns disease I received an appointment quickly. It took a huge effort on my part though.

    July 27, 2023
    SUGAR HOUSE HEALTH CENTER

    I always enjoy my visits with Keisa.

    July 12, 2023
    SUGAR HOUSE HEALTH CENTER

    Keisha was very professional and cordial.

    July 09, 2023
    REDWOOD HEALTH CENTER

    She is very professional and respectful and gives excellent advice and support.

    May 25, 2023
    REDWOOD HEALTH CENTER

    She has been my provider for over 20 years and she has always taken good care of me

    May 25, 2023
    REDWOOD HEALTH CENTER

    She is open, honest and easy to talk with!

  • Keisa M. Lynch, DNP, APRN, FNP is a family nurse practitioner in the Department of Gastroenterology and Hepatology at the University of Utah School of Medicine and an Associate Professor at the University of Utah in the College of Nursing Doctorate Program. She is also the lead advanced practice provider (APP) within her division and a provider informaticist with EPIC. She also has special interests in inflammatory bowel disease and hepatology, especially viral hepatitis.

    Dr. Lynch completed her undergraduate degree in nursing at Weber State University followed by a Master’s of Science in Nursing (MSN) as a family nurse practitioner (FNP) at Westminster College. Dr. Lynch then completed her Doctor of Nursing Practice (DNP) degree at the University of Utah. Dr. Lynch has been recognized with the APP Clinical Excellence Award from the University of Utah internal medicine division and has lectured around the country on the topics of viral hepatitis, inflammatory bowel disease, non-alcoholic fatty liver disease, and how APPs can advance the academic and clinical mission. She was recently awarded a grant for assessing prevalence of hepatitis delta in Utah titled: The Changing Landscape: HDV Reflex Testing and Linkage to Care in the Utah Population. She is passionate about education, quality improvement, mentoring, professional development, leadership and research. Dr. Lynch is also a member of the American College of Gastroenterology Advanced Practice Providers committee and a co-mentor in Project HCV ECHO.

    Education history

    Doctoral Training Doctor of Nursing Practice - University of Utah DNP
    Family Nurse Practitioner - Westminster College M.S.N.
    Undergraduate Nursing - Weber State University BSN

    Selected Publications

    Journal Article

    1. Mark S Sulkowski, Anthony Martinez, Gia L Tyson, Kathleen Scholz, Ricardo A Franco, Anita Kohli, Susan F Julius, Paulina Deming, Scott A Fink, Keisa Lynch, Marina Roytman, Tuesdae R Stainbrook, Marshe D Turner, Matthew Viera-Briggs, Christian B Ramers (2024). Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs. Journal of Viral Hepatitis.
    2. Gallegos-Orozco JF, Kim R, Thiesset HF, Hatch J, Lynch K, Chaly T Jr, Shihab F, Ahmed F, Hall I, Campsen J (2016). Early Results of Pilot Study Using Hepatitis C Virus (HCV) Positive Kidneys to Transplant HCV Infected Patients with End-Stage Renal Disease Allowing for Successful Interferon-Free Direct Acting Antiviral Therapy after Transplantation. Cureus, 8(11), e890. (Read full article)
  • News & Podcasts